COMMUNIQUÉS West-GlobeNewswire

Receptor Holdings Adds Alex Casdin to Board of Directors
08/04/2019
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings (RHI). Mr. Casdin has a [...]
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
08/04/2019
ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2019, the Company entered into a securities purchase agreement with [...]
Share buy-back week 14/2019
08/04/2019
Announcement 8 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Sarepta Therapeutics’ Gene Therapy Limb-Girdle Muscular Dystrophy Type 2E Clinical Data has been Accepted for a Late-breaking Oral Presentation at the 2019 MDA Clinical and Scientific Conference
08/04/2019
--Six additional poster presentations highlighting data from Sarepta’s RNA and gene therapy programs also accepted-- CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the [...]
Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
08/04/2019
FDA Agrees to Primary Endpoint of Change in Moderate to Vigorous Physical Activity from Baseline to Week 16, Measured by Actigraphy FDA Also Agrees on Modification of Ongoing Phase 2b Study into a Phase 2/3 Trial, with [...]
Spero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
08/04/2019
Five presentations on SPR994 and cUTI resistance trends at ECCMID provide support for Phase 3 program and unmet need CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi- [...]
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
08/04/2019
– New Allowance by U.S. Patent and Trademark Office Includes irritable bowel syndrome (IBS) test kit panel – IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the [...]
Auransa to Participate in BioCentury's 26th Annual Future Leaders in the Biotech Industry Conference
08/04/2019
PALO ALTO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced [...]
Managers’ transactions
08/04/2019
Company announcement No. 7/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen [...]
REPEAT - RavenQuest Secures Health Canada Cultivation License at Edmonton Facility
08/04/2019
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
08/04/2019
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its proprietary VetaFilm™ oral [...]
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
08/04/2019
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel 17β-estradiol [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT003, Nasal Nalmefene, for Treatment of Synthetic Opioid Overdose
08/04/2019
Data published online in the Journal of Pharmacology and Experimental Therapeutics SANTA MONICA, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company [...]
Kaleido Biosciences Announces Key Appointments to Leadership Team
08/04/2019
Johan van Hylckama Vlieg, Ph.D., Named Chief Scientific Officer and Clare Fisher Appointed Chief Business Officer LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a [...]
HealthLynked Announces the Addition of Richard Williamson as New VP of Marketing
08/04/2019
NAPLES, Fla., April 08, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp ( OTCQB: HLYK ) (the “Company”), a leader in digital healthcare technology, today announced the appointment of Richard Williamson as Vice President of [...]
Cue Biopharma to Present Immuno-STAT Platform Technology at PEGs Boston 2019
08/04/2019
CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc. (NASDAQ: CUE), an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
TYME’s SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs
08/04/2019
New oral approach aimed at disrupting cancer metabolism SM-88 is an investigational Cancer Metabolism-Based Therapy (CMBTs TM ) that has demonstrated responses across 15 different cancers 30 patients enrolled in study [...]
Profound Medical Analyst & Investor Day Agenda
08/04/2019
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
PDS Biotechnology Appoints Stephen Glover to its Board of Directors
08/04/2019
BERKELEY HEIGHTS, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing novel multifunctional immunotherapeutic products, today [...]

Pages